Technical Analysis for VRML - Vermillion, Inc.

Grade Last Price % Change Price Change
grade B 3.3 -12.00% -0.45
VRML closed down 12.0 percent on Thursday, June 4, 2020, on 2.59 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical VRML trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Calm After Storm Range Contraction -12.00%
Parabolic Rise Strength -12.00%
Upper Bollinger Band Walk Strength -12.00%
Wide Bands Range Expansion -12.00%
Upper Bollinger Band Touch Strength -12.00%
Volume Surge Other -14.29%
Wide Range Bar Range Expansion -14.29%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Vermillion, Inc., together with its subsidiaries, engages in the discovery, development, and commercialization of diagnostic tests that help physicians diagnose, treat, and enhance outcomes for patients. The company develops diagnostic tests in the fields of oncology, cardiology, and women's health. Its lead product is OVA1, an ovarian cancer blood test for pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. The company is also involved in developing various programs in other clinical aspects of ovarian cancer, as well as in peripheral arterial disease. Vermillion, Inc. has strategic alliance agreement with Quest Diagnostics Incorporated to develop and commercialize diagnostic tests. It serves clinical reference laboratories, hospital laboratories, and physician offices. The company was formerly known as Ciphergen Biosystems, Inc. and changed its name to Vermillion, Inc. in August 2007. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas.
Medicine Health Medical Specialties Oncology Ovarian Cancer Diagnostic Tests Corning Inc. Peripheral Arterial Disease Quest Diagnostics

Is VRML a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.61
52 Week Low 0.355
Average Volume 635,476
200-Day Moving Average 0.98
50-Day Moving Average 1.82
20-Day Moving Average 2.75
10-Day Moving Average 3.22
Average True Range 0.50
ADX 53.35
+DI 41.76
-DI 9.84
Chandelier Exit (Long, 3 ATRs ) 4.12
Chandelier Exit (Short, 3 ATRs ) 3.36
Upper Bollinger Band 4.03
Lower Bollinger Band 1.48
Percent B (%b) 0.71
BandWidth 92.76
MACD Line 0.53
MACD Signal Line 0.47
MACD Histogram 0.0624
Fundamentals Value
Market Cap 185.33 Million
Num Shares 56.2 Million
EPS -0.22
Price-to-Earnings (P/E) Ratio -15.00
Price-to-Sales 25.03
Price-to-Book 16.79
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.32
Resistance 3 (R3) 4.37 4.08 4.15
Resistance 2 (R2) 4.08 3.82 4.06 4.09
Resistance 1 (R1) 3.69 3.66 3.55 3.64 4.04
Pivot Point 3.40 3.40 3.33 3.38 3.40
Support 1 (S1) 3.01 3.14 2.87 2.96 2.56
Support 2 (S2) 2.72 2.98 2.70 2.51
Support 3 (S3) 2.33 2.72 2.45
Support 4 (S4) 2.28